Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
1.
Curr Pharm Des ; 29(41): 3324-3339, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38111115

RESUMEN

INTRODUCTION: In the present study, we aimed to investigate the extraction and identification of the potential phytochemicals from the Methanolic Extract of Dryopteris ramosa (MEDR) using GC-MS profiling for validating the traditional uses of MEDR its efficacy in inflammations by using in-vitro, in-vivo and in silico approaches in anti-inflammatory models. METHODS: GC-MS analysis confirmed the presence of a total of 59 phytochemical compounds. The human red blood cells (HRBC) membrane stabilization assay and heat-induced hemolysis method were used as in-vitro anti-inflammatory activity of the extract. The in-vivo analysis was carried out through the Xylene-induced mice ear oedema method. It was found that MEDR at a concentration of 20 µg, 30 µg, and 40 µg showed 35.45%, 36.01%, and 36.33% protection to HRBC in a hypotonic solution, respectively. At the same time, standard Diclofenac at 30 µg showed 45.31% protection of HRBC in a hypotonic solution. RESULTS: The extract showed inhibition of 25.32%, 26.53%, and 33.31% cell membrane lysis at heating at 20 µg, 30 µg, and 40 µg, respectively. In comparison, standard Diclofenac at 30 µg showed 50.49% inhibition of denaturation to heat. Methanolic extract of the plant exhibited momentous inhibition in xylene-induced ear oedema in mice treated with 30 µg extract were 47.2%, 63.4%, and 78.8%, while inhibition in mice ear oedema treated with 60 µg extract was 34.7%, 43.05%, 63.21% and reduction in ear thickness of standard drug were 57.3%, 59.54%, 60.42% recorded at the duration of 1, 4 and 24 hours of inflammation. Molecular docking and simulations were performed to validate the anti-inflammatory role of the phytochemicals that revealed five potential phytochemicals i.e. Stigmasterol,22,23dihydro, Heptadecane,8methyl, Pimaricacid, Germacrene and 1,3Cyclohexadiene,_5(1,5dimethyl4hexenyl)-2methyl which revealed potential or significant inhibitory effects on cyclooxygenase-2 (COX-2), tumour necrosis factor (TNF-α), and interleukin (IL-6) in the docking analysis. CONCLUSION: The outcome of the study signifies that MEDR can offer a new prospect in the discovery of a harmonizing and alternative therapy for inflammatory disease conditions.


Asunto(s)
Dryopteris , Ratones , Humanos , Animales , Xilenos/efectos adversos , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Extractos Vegetales/química , Simulación del Acoplamiento Molecular , Diclofenaco/efectos adversos , Soluciones Hipotónicas/efectos adversos , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Inflamación/tratamiento farmacológico , Edema/inducido químicamente , Edema/tratamiento farmacológico , Metanol/efectos adversos , Factor de Necrosis Tumoral alfa
2.
Metab Brain Dis ; 38(7): 2355-2367, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37436587

RESUMEN

Epilepsy, a chronic neurological condition, impacts millions of individuals globally and remains a significant contributor to both illness and mortality. Available antiepileptic drugs have serious side effects which warrants to explore different medicinal plants used for the management of epilepsy reported in Traditional Indian Medicinal System (TIMS). Therefore, we explored the antiepileptic potential of the Grewia tiliaefolia (Tiliaeceae) which is known for its neuroprotective properties. Aerial parts of G. tiliaefolia were subjected to extraction with increasing order of polarity viz. hexane, chloroform and methanol. Antioxidant potential of hexane, chloroform and methanol extracts of G. tiliaefolia was evaluated by 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay, total antioxidant capacity (TAC) assay, reducing power assay (RPA) and DNA nicking assay. Additionally, quantitative antioxidant assays were also conducted to quantify total phenolic (TPC) and total flavonoid content (TFC). As revealed by in vitro assays, methanol extract was found to contain more phenolic content. Hence, the methanol extract was further explored for its anticonvulsant potential in pentylenetetrazole (PTZ) induced acute seizures in mice. The methanol extract (400 mg/kg) significantly increased the latency to occurrence of myoclonic jerks and generalized tonic clonic seizures (GTCS). Additionally, it also reduced duration and seizure severity score associated with GTCS. The Grewia tiliaefolia methanol extract was further screened by Ultra High-Performance Liquid Chromatography (UHPLC) for presence of polyphenolic compounds, among which gallic acid and kaempferol were present in higher amount and were further analysed by in silico study to predict their possible binding sites and type of interactions these compounds show with gamma amino butyric acid (GABA) receptor and glutamate α amino-3- hydroxyl-5-methyl-4-isoxazolepropionic acid (Glu-AMPA) receptor. It was revealed that gallic acid and kaempferol had shown agonistic interaction for GABA receptor and antagonistic interaction for Glu-AMPA receptor. We concluded that G. tiliaefolia showed anticonvulsant potential possibly because of gallic acid and kaempferol possibly mediated through GABA and Glu-AMPA receptor.


Asunto(s)
Epilepsia , Grewia , Ratones , Animales , Anticonvulsivantes/efectos adversos , Pentilenotetrazol/toxicidad , Grewia/química , Hexanos/efectos adversos , Quempferoles , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Metanol/efectos adversos , Cloroformo/efectos adversos , Receptores AMPA , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Epilepsia/inducido químicamente , Epilepsia/tratamiento farmacológico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Extractos Vegetales/química , Ácido Gálico/uso terapéutico , Ácido gamma-Aminobutírico
3.
Braz. J. Pharm. Sci. (Online) ; 59: e21220, 2023. graf
Artículo en Inglés | LILACS | ID: biblio-1439533

RESUMEN

Abstract Exposure to methanol can cause serious consequences such as permanent visual disturbances and death. The heart tissue is highly vulnerable to ATP deficiency. Our study aimed to investigate whether exogenous ATP administration may alleviate methanol-induced ATP deficiency and subsequent oxidative damage in rat heart tissue. A total of 30 rats were divided into equal five groups; Healthy Group (HG), Methotrexate (MXG), Methanol (MeOH), Methotrexate+Methanol (MXM), and Methotrexate+Methanol+ATP (MMA) groups. We inhibited tetrahydrofolate synthesis by methotrexate to induce methanol toxicity. Methotrexate was administered to MXG, MXM, and MMA group animals for seven days with a catheter directly to the stomach at a 0,3 mg/kg dose per day. At the end of this period, % 20 methanol at a dose of 3 g/kg was administered to MeOH, MMA and MXM group animals. Immediately after methanol application, MMA group animals were injected with ATP at a 4 mg/kg dose intraperitoneally. Blood samples and heart tissues were used for biochemical analysis and histopathological examination. Co-exposure to methanol and methotrexate substantially exacerbated cardiac damage, indicating the potent cardiotoxic effects of methanol. However, the administration of exogenous ATP to MMA group animals brought biochemical oxidative damage parameters and histopathological findings closer to HG.


Asunto(s)
Animales , Masculino , Ratas , Adenosina Trifosfato/análisis , Metanol/efectos adversos , Cardiotoxicidad/clasificación
4.
Iran J Med Sci ; 46(5): 395-398, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34539014

RESUMEN

In April 2018, a 20-year-old man with a history of methanol intoxication from an alcoholic drink two years ago, when he was 18 years old, was referred to Nikookari Eye Hospital in Tabriz, Iran. He was admitted to emergency service and underwent eight hours of hemodialysis at the time of poisoning. His past medical history was negative, and he did not take any medication after discharge. The patient had a driving license and never experienced any visual problems before. At presentation, his visual acuity was 160/200 in both eyes with the main complaint of visual field deterioration. Other neurologic exams and brain magnetic resonance imaging (MRI) were reported normal by a neurologist. Optic disc cupping was near total in both eyes with a very narrow remaining rim. Optic disc cupping was very similar to glaucomatous cupping. Intraocular pressure was checked several times via Goldmann tonometry and was 13 mmHg. There was no history of refractive surgery leading to thin cornea. Based on this case, methanol poisoning can mimic glaucomatous optic disc cupping. This is the first case report of methanol toxicity-related optic disc cupping from Iran.


Asunto(s)
Metanol/toxicidad , Disco Óptico/efectos de los fármacos , Humanos , Irán , Masculino , Metanol/efectos adversos , Disco Óptico/fisiopatología , Tonometría Ocular/métodos , Adulto Joven
5.
Klin Lab Diagn ; 64(2): 78-82, 2019.
Artículo en Ruso | MEDLINE | ID: mdl-30917247

RESUMEN

This study is devoted to assessing the state of the mucous membrane of the upper respiratory tract of the workers of chemical production of methanol and formaldehyde. A total of 450 workers were examined by rhinocytogram (RCH) evaluation. As a result of the study, studies have found that people with work experience of up to 10 years in the production of methanol and formaldehyde in the RCH the siggns of chronic inflammation is more likely to be detected. More experienced patients (more than 10 years of work experience) studies have found the establishment of morphological signs of protective and degenerative changes in ciliated epithelium, and there is a high degree of connection between the development of protective changes and the exposure to chemicals (RR = 2.71, etiological share, EF = 56.4%) and the development of degenerative changes (RR = 3.28, EF = 65.4%). These results are considered by the authors as the biomarkers of the development of a professionally conditioned lesion of the upper respiratory tract.


Asunto(s)
Formaldehído/efectos adversos , Metanol/efectos adversos , Membrana Mucosa/patología , Exposición Profesional/efectos adversos , Humanos , Inflamación/patología , Membrana Mucosa/efectos de los fármacos
6.
Alcohol ; 75: 99-103, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30640075

RESUMEN

This study assessed the ethanol and methanol contents of homemade spirit (Kachasu) sold in Blantyre, Malawi. The likelihood of ethanol and methanol toxicity, respectively, was determined through Monte Carlo simulations using reported Kachasu intake volumes of 21 consumers and the determined methanol and ethanol contents. Ethanol concentration, in samples from 20 different distillers, ranged from 11 to 55% v/v. Methanol was detected in 10 of the 20 samples (0.01-0.28% v/v). The likely mean ethanol intake of drinkers in Blantyre was found to be 214 ± 93 mL per day (90% CI, 68.9-373.4 mL), and mean methanol intake was 0.44 ± 0.37 mL (90% CI, 0.03-1.17 mL). The intake values translated to mean blood ethanol and methanol concentrations of 38 ± 16 mg/mL and 0.05 ± 0.04 mg/mL, respectively. Therefore, the risk of methanol toxicity was considered as negligible. However, there was a high risk of ethanol toxicity. Since production and selling of Kachasu are already illegal in Malawi, enforcement of regulations should be strengthened to reverse the current situation where Kachasu is being distilled and sold openly even within cities. Consumers should also be sensitized about the likely risks associated with consumption of Kachasu in Malawi so that they can make informed choices.


Asunto(s)
Consumo de Bebidas Alcohólicas/efectos adversos , Bebidas Alcohólicas/efectos adversos , Etanol/efectos adversos , Metanol/efectos adversos , Salud Pública/tendencias , Consumo de Bebidas Alcohólicas/sangre , Consumo de Bebidas Alcohólicas/tendencias , Etanol/administración & dosificación , Etanol/sangre , Humanos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/sangre , Malaui/epidemiología , Masculino , Metanol/administración & dosificación , Metanol/sangre , Distribución Aleatoria , Azúcares/efectos adversos , Zea mays/efectos adversos
7.
Int Arch Occup Environ Health ; 92(4): 551-557, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30535884

RESUMEN

PURPOSE: Recently, the international agency for research on cancer recommended that methanol should be recognized as a medium-priority, human cancer risk. Therefore, we performed an epidemiological study to evaluate the relationship between methanol exposure and the cancer mortality of Korean workers occupationally exposed to methanol. METHODS: The study cohort was composed of methanol-exposed 25,218 male workers, data on whom were available from the Korea Occupational Safety and Health Agency; all participants underwent methanol-associated medical check-ups at least once between January 2000 and December 2004. The durations of methanol exposure were categorized as < 10, 10-20, and ≥ 20 years. Workplace methanol exposure levels for each worker were divided into three grades. We compared their standardized cancer mortality rates (SMRs) to those of the general population. Intra-cohort hazard ratios were estimated using a Cox's proportional hazards model. RESULTS: We found no positive association between methanol exposure and cancer mortality. In terms of all cancer mortality, methanol-exposed workers exhibited significantly lower SMRs than the general population. In terms of other cancer mortality, no significant difference or trend was evident as a function of duration of methanol exposure. CONCLUSIONS: Although we found no significant correlation between methanol exposure and cancer mortality, we believe the work is meaningful; this is the first, large-scale, human epidemiological study. The carcinogenic potential of methanol remains an open question, and studies with longer-term follow-up periods are needed.


Asunto(s)
Metanol/efectos adversos , Neoplasias/mortalidad , Exposición Profesional/estadística & datos numéricos , Adulto , Carcinógenos , Causas de Muerte , Estudios de Cohortes , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/inducido químicamente , República de Corea/epidemiología
8.
Biomed Pharmacother ; 89: 1320-1330, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28320099

RESUMEN

Methanol-induced retinal toxicity, frequently associated with elevated free radicals and cell edema, is characterized by progressive retinal ganglion cell (RGC) death and vision loss. Previous studies investigated the effect of photomodulation on RGCs, but not the visual cortex. In this study, the effect of 670nm Light-Emitting Diode (LED) therapy on RGCs and visual cortex recovery was investigated in a seven-day methanol-induced retinal toxicity protocol in rats. Methanol administration showed a reduction in the number of RGCs, loss of neurons (neuronal nuclear antigen, NeuN+), activation of glial fibrillary acidic protein (GFAP+) expressing cells, suppression of brain-derived neurotrophic factor (BDNF+) positive cells, increase in apoptosis (caspase 3+) and enhancement of nitric oxide (NO) release in serum and brain. On the other hand, LED therapy significantly reduced RGC death, in comparison to the methanol group. In addition, the number of BDNF positive cells was significantly higher in the visual cortex of LED-treated group, in comparison to methanol-intoxicated and control groups. Moreover, LED therapy caused a significant decrease in cell death (caspase 3+ cells) and a significant reduction in the NO levels, both in serum and brain tissue, in comparison to methanol-intoxicated rats. Overall, LED therapy demonstrated a number of beneficial effects in decreasing oxidative stress and in functional recovery of RGCs and visual cortex. Our data suggest that LED therapy could be a potential condidate as a non-invasive approach for treatment of retinal damage, which needs further clinicl studies.


Asunto(s)
Apoptosis/fisiología , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Lóbulo Occipital/metabolismo , Lóbulo Occipital/fisiopatología , Animales , Apoptosis/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/fisiopatología , Muerte Celular/fisiología , Proteína Ácida Fibrilar de la Glía/metabolismo , Luz , Masculino , Metanol/efectos adversos , Óxido Nítrico/metabolismo , Lóbulo Occipital/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Fototerapia/métodos , Ratas , Ratas Wistar , Retina/efectos de los fármacos , Retina/metabolismo , Retina/fisiopatología , Células Ganglionares de la Retina/efectos de los fármacos , Células Ganglionares de la Retina/metabolismo , Células Ganglionares de la Retina/fisiología
9.
Curr Pharm Des ; 23(4): 586-595, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28120722

RESUMEN

BACKGROUND: Toxic optic neuropathies (TONs) often present with a gradual and bilateral decrease in visual acuity, scotomas and optic disc pallor. Obtaining an accurate history is the critical first step in determining the etiology of TONs. METHODS: This updated review contains a thorough analysis of the current PubMed-indexed literature on the most common agents responsible for TONs, including methanol, ethambutol, amiodarone, linezolid, tumor necrosis factor alpha inhibitors and phosphodiesterase 5 inhibitors. RESULTS: The reviewed articles are mainly case reports presenting new and controversial aspects of the above agents. New treatment strategies, such as erythropoietin for methanol optic neuropathy, are being proposed for TONs, a condition that was previously regarded as untreatable. CONCLUSION: TONs could cause significant disability due to visual impairment. In case of early diagnosis and drug withdrawal, most TONs are treatable. Patients need to be appropriately counseled, and prescribing physicians should be especially made aware of TON-inducing medications.


Asunto(s)
Amiodarona/efectos adversos , Etambutol/efectos adversos , Linezolid/efectos adversos , Metanol/efectos adversos , Enfermedades del Nervio Óptico/inducido químicamente , Inhibidores de Fosfodiesterasa 5/efectos adversos , Eritropoyetina/uso terapéutico , Humanos , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/tratamiento farmacológico
10.
Artículo en Inglés | MEDLINE | ID: mdl-26006090

RESUMEN

BACKGROUND: Alcohol variants such as ethanol and methanol are simple organic compounds widely used in foods, pharmaceuticals, chemical synthesis, etc. Both are becoming an emerging health problem; abuse of ethanol containing beverages can lead to disparate health problems and methanol is highly toxic and unfit for consumption. METHODS AND RESULTS: This review summarizes the basic knowledge about ethanol and methanol toxicity, the effect mechanism on the body, the current care of poisoned individuals and the implication of alcohols in the development of diseases. Alcohol related dementia, stroke, metabolic syndrome and hepatitis are discussed as well. Besides ethanol, methanol toxicity and its biodegradation pathways are addressed. CONCLUSIONS: The impact of ethanol and methanol on the body is shown as case reports, along with a discussion on the possible implication of alcohol in Alzheimer's disease and antidotal therapy for methanol poisoning. The role of ethanol in cancer and degenerative disorders seems to be underestimated given the current knowledge. Treatment in case of poisoning is another issue that remains unresolved even though effective protocols and drugs exist.


Asunto(s)
Etanol/efectos adversos , Metanol/efectos adversos , Alcohol Deshidrogenasa/efectos de los fármacos , Alcohol Deshidrogenasa/metabolismo , Bebidas Alcohólicas/efectos adversos , Bebidas Alcohólicas/análisis , Alcoholismo/etiología , Alcoholismo/metabolismo , Aldehído Deshidrogenasa/efectos de los fármacos , Aldehído Deshidrogenasa/metabolismo , Antídotos/uso terapéutico , Etanol/metabolismo , Etanol/envenenamiento , Humanos , Metanol/metabolismo , Metanol/envenenamiento , Receptores de Superficie Celular/efectos de los fármacos
11.
Br J Pharmacol ; 172(15): 3929-43, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25953698

RESUMEN

BACKGROUND AND PURPOSE: Dimethyl fumarate (DMF) is a newly approved drug for the treatment of relapsing forms of multiple sclerosis and relapsing-remitting multiple sclerosis. Here, we investigated the effects of DMF and its metabolites mono-methylfumarate (MMF and methanol) on different gastrointestinal cancer cell lines and the underlying molecular mechanisms involved. EXPERIMENTAL APPROACH: Cell viability was measured by the MTT or CCK8 assay. Protein expressions were measured by Western blot analysis. LDH release, live- and dead-cell staining, intracellular GSH levels, and mitochondrial membrane potential were examined by using commercial kits. KEY RESULTS: DMF but not MMF induced cell necroptosis, as demonstrated by the pharmacological tool necrostatin-1, transmission electron microscopy, LDH and HMGB1 release in CT26 cells. The DMF-induced decrease in cellular GSH levels as well as cell viability and increase in reactive oxygen species (ROS) were inhibited by co-treatment with GSH and N-acetylcysteine (NAC) in CT26 cells. DMF activated JNK, p38 and ERK MAPKs in CT26 cells and JNK, p38 and ERK inhibitors partially reversed the DMF-induced decrease in cell viability. GSH or NAC treatment inhibited DMF-induced JNK, p38, and ERK activation in CT26 cells. DMF but not MMF increased autophagy responses in SGC-7901, HCT116, HT29 and CT26 cancer cells, but autophagy inhibition did not prevent the DMF-induced decrease in cell viability. CONCLUSION AND IMPLICATIONS: DMF but not its metabolite MMF induced necroptosis in colon cancer cells through a mechanism involving the depletion of GSH, an increase in ROS and activation of MAPKs.


Asunto(s)
Apoptosis/efectos de los fármacos , Neoplasias del Colon/patología , Dimetilfumarato/efectos adversos , Glutatión/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Necrosis/inducido químicamente , Especies Reactivas de Oxígeno/metabolismo , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Neoplasias del Colon/enzimología , Neoplasias del Colon/metabolismo , Fumaratos/efectos adversos , Proteína HMGB1/metabolismo , Humanos , L-Lactato Deshidrogenasa/metabolismo , Maleatos/efectos adversos , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Metanol/efectos adversos , Ratones , Necrosis/metabolismo
12.
Regul Toxicol Pharmacol ; 69(2): 178-86, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24709515

RESUMEN

Due largely to the controversy concerning the potential human health effects from exposure to formaldehyde gas in conjunction with the misunderstanding of the well-established equilibrium relationship with its hydrated reaction product, methylene glycol, the concept of chemical equivalence between these two distinctly different chemicals has been adopted by regulatory authorities. Chemical equivalence implies not only that any concentration of methylene glycol under some condition of use would be nearly or completely converted into formaldehyde gas, but also that these two substances would be toxicologically equivalent as well. A relatively simple worst case experiment using 37% formalin (i.e., concentrated methylene glycol) dispels the concept of chemical equivalence and a review of relevant literature demonstrates that methylene glycol has no inherent toxicity apart from whatever concentration of formaldehyde that might be present in equilibrium with such solutions.


Asunto(s)
Formaldehído/química , Formaldehído/toxicidad , Metanol/análogos & derivados , Formaldehído/efectos adversos , Humanos , Metanol/efectos adversos , Metanol/química , Metanol/toxicidad
13.
West Indian med. j ; 62(1): 84-86, Jan. 2013. ilus, tab
Artículo en Inglés | LILACS | ID: biblio-1045593

RESUMEN

A 60-year old female patient was found comatosed at home and taken to the hospital's Emergency Department by her relatives. It was learnt that she wrapped her knees with spirit-impregnated cotton pad for pain for one week. On physical examination, only a colour change of purple violet on her knees was noted. Metabolic acidosis with increased anion gap was detected by arterial blood analysis. The patient underwent haemodialysis. She was discharged from the hospital with no complaints, alert and rational following five days of follow-up treatment, with the diagnosis of methyl alcohol poisoning.


Una paciente de 60 años de edad fue hallada en estado comatoso en su casa, y trasladada por sus familiares al departamento de emergencias del hospital. Se supo que la paciente había sentido dolor en sus rodillas, y las cubrió con almohadillas de algodón impregnadas de metanol por espacio de una semana. Al realizarse el examen físico, sólo se observó un cambio de color violeta púrpura en sus rodillas. El análisis de sangre arterial reveló acidosis metabólica con hiato iónico elevado. A la paciente se le practicó una hemodiálisis. Fue dada de alta del hospital sin dolencias, consciente, y en su sano juicio, luego de cinco días de seguimiento de su tratamiento, tras de haber sido diagnosticada con envenamiento por alcohol metílico.


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Acidosis/inducido químicamente , Diálisis Renal , Artralgia/tratamiento farmacológico , Metanol/efectos adversos , Resultado del Tratamiento , Metanol/administración & dosificación , Manejo del Dolor
14.
Biol Trace Elem Res ; 149(1): 78-85, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22528777

RESUMEN

This paper is a study on the effects on the amounts of trace elements in case of possible repeat accidental or environmental exposure with fish oil biodiesel. For this purpose, 35 male Wistar albino rats were used in the study. Rats were divided into five groups. The first group was determined as the control group. The rats in this group were gavaged orally with 250 mg/kg sunflower oil. The rats in the second and third groups were administered by oral gavage of 250 mg/kg (D1) and 500 mg/kg (D2) diesel fuel mixed with equal amounts of sunflower oil, respectively. The rats in the fourth group were administered by oral gavage of 250 mg/kg fish oil biodiesel (F1) and the rats in the fifth group were administered by oral gavage of 500 mg/kg fish oil biodiesel (F2), both mixed with equal amounts of sunflower oil. At the end of the study, bioelement concentrations in the serum and the kidney, lung, and liver tissues were measured using inductively coupled plasma-optical emission spectroscopy. It was observed that serum Ca, Mg, and Sr concentrations were significantly (p<0.001) higher and Cu concentration was significantly (p<0.01) higher in the control group than in the biodiesel groups. Kidney Mg concentration was significantly (p<0.01) lower in the control group than in the diesel groups. Kidney Mg concentration was significantly (p<0.001) lower in the D2 group than in the F2 group. Kidney Mg concentration was significantly (p<0.01) lower in the control group than in the diesel groups. Lung Cd, Co, Cu, Cr, Na, and Zn concentrations were different significantly higher in the control group than in the other groups. Liver Al concentration was different significantly higher in the control group than in the other groups. Liver Ca concentration was significantly (p<0.05) higher in the control group than in the biodiesel groups. Serum and lung tissue bioelements concentrations were lower in diesel and biodiesel groups than in control group. Due to consumption for biochemical reaction of these elements, bioelements concentration could be low in diesel and biodiesel groups. Some trace elements concentrations in the kidney and liver were very high in the diesel groups. High concentration of these elements in the diesel groups might cause toxic effects. Fish oil biodiesel could be chosen as an alternative fuel instead of diesel fuel.


Asunto(s)
Biocombustibles/efectos adversos , Ésteres/efectos adversos , Aceites de Pescado/efectos adversos , Gasolina/efectos adversos , Metanol/metabolismo , Oligoelementos/metabolismo , Administración Oral , Animales , Calcio/sangre , Exposición a Riesgos Ambientales/efectos adversos , Ésteres/administración & dosificación , Aceites de Pescado/administración & dosificación , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Magnesio/sangre , Masculino , Metales Pesados/sangre , Metanol/efectos adversos , Aceites de Plantas/administración & dosificación , Ratas , Ratas Wistar , Análisis Espectral/métodos , Estroncio/sangre , Aceite de Girasol , Pruebas de Toxicidad , Oligoelementos/sangre
16.
Contact Dermatitis ; 62(4): 221-4, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20236159

RESUMEN

BACKGROUND: Frequencies of sensitization to formaldehyde among US patients patch tested for suspected contact dermatitis are higher than in Europe. Cosmetics are an important source of contact with formaldehyde. OBJECTIVES: To acquire data on the frequency of use of formaldehyde-releasers in cosmetics sold in the USA and Europe and their use concentrations. To assess whether any observed differences may contribute to the discrepancies in sensitization rates. METHODS: Enquiries with Food and Drug Administration (FDA), the European Cosmetics Association, and the Dutch Cosmetics Association. Reading the labels of skin care cosmetics in a local drugstore. RESULTS: The FDA provided data on the presence of formaldehyde and releasers. Nearly one fifth of all cosmetics contain a releaser. In 25% of 496 examined skin care products, releasers were present. In comparable FDA data categories, the percentage was 24. No data were found on use concentrations of the releasers in cosmetics in either the USA or Europe. CONCLUSIONS: The percentages of stay-on skin care products containing a formaldehyde-releaser are virtually identical in the USA (FDA data) and our local drugstore sample. However, this does not necessarily imply that cosmetics play no part in the differences in formaldehyde sensitization rates.


Asunto(s)
Cosméticos/efectos adversos , Cosméticos/química , Dermatitis Alérgica por Contacto/epidemiología , Dermatitis Alérgica por Contacto/etiología , Formaldehído/efectos adversos , Dioxanos/efectos adversos , Europa (Continente)/epidemiología , Humanos , Hidantoínas/efectos adversos , Metanol/efectos adversos , Metanol/análogos & derivados , Metenamina/efectos adversos , Metenamina/análogos & derivados , Éteres Metílicos/efectos adversos , Prevalencia , Glicoles de Propileno/efectos adversos , Estados Unidos/epidemiología , Urea/efectos adversos , Urea/análogos & derivados
17.
Contact Dermatitis ; 62(1): 2-17, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20136875

RESUMEN

In this part of a series of review articles on formaldehyde-releasers and their relationship to formaldehyde contact allergy, formaldehyde-releasers in cosmetics are discussed. In this first part of the article, key data are presented including frequency of sensitization and of their use in cosmetics. In Europe, low frequencies of sensitization have been observed to all releasers: 2-bromo-2-nitropropane-1,3-diol 0.4-1.2%, diazolidinyl urea 0.5-1.4%, imidazolidinyl urea 0.3-1.4%, quaternium-15 0.6-1.9% (for DMDM hydantoin no recent data are available). All releasers score (far) higher prevalences in the USA; the possible explanations for this are discussed. The relevance of positive patch test reactions has been insufficiently investigated. In the USA, approximately 20% of cosmetics and personal care products (stay-on products: 17%, rinse-off products 27%) contain a formaldehyde-releaser. The use of quaternium-15 is decreasing. For Europe, there are no comparable recent data available. In the second part of the article, the patch test relationship of the releasers in cosmetics to formaldehyde contact allergy will be reviewed and it will be assessed whether products preserved with formaldehyde-releasers may contain enough free formaldehyde to pose a threat to individuals who have contact allergy to formaldehyde.


Asunto(s)
Cosméticos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Formaldehído/efectos adversos , Cosméticos/administración & dosificación , Cosméticos/análisis , Dermatitis Alérgica por Contacto/epidemiología , Dioxanos/efectos adversos , Europa (Continente)/epidemiología , Femenino , Formaldehído/administración & dosificación , Formaldehído/análisis , Humanos , Hidantoínas/efectos adversos , Masculino , Metanol/efectos adversos , Metanol/análogos & derivados , Metenamina/efectos adversos , Metenamina/análogos & derivados , Éteres Metílicos/efectos adversos , Glicoles de Propileno/efectos adversos , Sarcosina/efectos adversos , Sarcosina/análogos & derivados , Estados Unidos/epidemiología , Urea/efectos adversos , Urea/análogos & derivados
18.
Contact Dermatitis ; 62(1): 18-31, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20136876

RESUMEN

This is the second part of an article on formaldehyde-releasers in cosmetics. The patch test relationship between the releasers in cosmetics to formaldehyde contact allergy is reviewed and it is assessed whether products preserved with formaldehyde-releasers may contain enough free formaldehyde to pose a threat to individuals with contact allergy to formaldehyde. There is a clear relationship between positive patch test reactions to formaldehyde-releasers and formaldehyde contact allergy: 15% of all reactions to 2-bromo-2-nitropropane-1,3-diol and 40-60% of the reactions to the other releasers are caused by a reaction to the formaldehyde in the test material. There is only fragmented data on the amount of free formaldehyde in cosmetics preserved with formaldehyde donors. However, all releasers (with the exception of 2-bromo-2-nitropropane-1,3-diol, for which adequate data are lacking) can, in the right circumstances of concentration and product composition, release >200 p.p.m. formaldehyde, which may result in allergic contact dermatitis. Whether this is actually the case in any particular product cannot be determined from the ingredient labelling. Therefore, we recommend advising patients allergic to formaldehyde to avoid leave-on cosmetics preserved with quaternium-15, diazolidinyl urea, DMDM hydantoin, or imidazolidinyl urea, acknowledging that many would tolerate some products.


Asunto(s)
Cosméticos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Formaldehído/efectos adversos , Cosméticos/administración & dosificación , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Alérgica por Contacto/epidemiología , Dioxanos/efectos adversos , Europa (Continente)/epidemiología , Formaldehído/administración & dosificación , Humanos , Hidantoínas/administración & dosificación , Hidantoínas/efectos adversos , Metanol/efectos adversos , Metanol/análogos & derivados , Metenamina/administración & dosificación , Metenamina/efectos adversos , Metenamina/análogos & derivados , Éteres Metílicos/efectos adversos , Nitroparafinas/administración & dosificación , Nitroparafinas/efectos adversos , Pruebas del Parche , Propano/administración & dosificación , Propano/efectos adversos , Propano/análogos & derivados , Riesgo , Estados Unidos/epidemiología , Urea/administración & dosificación , Urea/efectos adversos , Urea/análogos & derivados
19.
Med Hypotheses ; 74(3): 493-6, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19896282

RESUMEN

Until 200 years ago, methanol was an extremely rare component of the human diet and is still rarely consumed in contemporary hunter and gatherer cultures. With the invention of canning in the 1800s, canned and bottled fruits and vegetables, whose methanol content greatly exceeds that of their fresh counterparts, became far more prevalent. The recent dietary introduction of aspartame, an artificial sweetener 11% methanol by weight, has also greatly increased methanol consumption. Moreover, methanol is a major component of cigarette smoke, known to be a causative agent of many diseases of civilization (DOC). Conversion to formaldehyde in organs other than the liver is the principal means by which methanol may cause disease. The known sites of class I alcohol dehydrogenase (ADH I), the only human enzyme capable of metabolizing methanol to formaldehyde, correspond to the sites of origin for many DOC. Variability in sensitivity to exogenous methanol consumption may be accounted for in part by the presence of aldehyde dehydrogenase sufficient to reduce the toxic effect of formaldehyde production in tissue through its conversion to the much less toxic formic acid. The consumption of small amounts of ethanol, which acts as a competitive inhibitor of methanol's conversion to formaldehyde by ADH I, may afford some individuals protection from DOC.


Asunto(s)
Enfermedad Crónica/epidemiología , Civilización , Susceptibilidad a Enfermedades/inducido químicamente , Susceptibilidad a Enfermedades/fisiopatología , Metanol/efectos adversos , Modelos Biológicos , Humanos , Medición de Riesgo
20.
Rio de Janeiro; s.n; 2010. 153 p. tab, graf.
Tesis en Portugués | LILACS | ID: lil-589570

RESUMEN

O metanol é um agente químico com características neurotóxico utilizados como matéria prima para a fabricação do biodiesel. Acredita-se que os efeitos após exposição crônica sejam semelhantes àqueles da exposição aguda, porém menos severos. Estes efeitos incluem distúrbios visuais e sob o sistema nervoso central. Por meio de uma pesquisa qualitativa foram identificadas as principais fontes de exposição ao metanol, população exposta e sinais e sintomas recentes num universo de 42 trabalhadores de uma usina de processamento de biodiesel no município de Quixadá, Brasil. Foram identificados oito possíveisfontes de emissão e grupo de trabalhadores potencialmente expostos ao metanol. Entre os grupos expostos, encontram-se os trabalhadores da equipe de operadores, técnicos emmanutenção, apoio operacional, auxiliares de laboratório e, ainda, o pessoal que desempenha as atividades durante o descarregamento do produto em questão. A análise da situação desaúde dos trabalhadores revelou que a maioria dos indivíduos potencialmente expostos já apresenta sintomatologias pré- existentes tais como dores de cabeça, formigamento, azia equeimação. Irritação (38,1 por cento), ansiedade (35,7 por cento), insônia (64,3 por cento) e, principalmente, dor de cabeça (64,35 por cento) são as queixas recentes mais importantes associadas aos sintomas neurotóxicos. Por outro lado, os sinais e sintomas recentes, que podem estar relacionados à exposição de metanol foram irritação nos olhos (38,1 por cento), dificuldades para respirar (23,8 por cento) ecâimbras (19 por cento).


Methanol is a chemical agent with neurotoxic characteristics used as chief component for biodiesel production. It is believed that symptoms developed from chronic exposure of methanol are similar to those of acute exposure, however less severe. The symptoms identified include visual and central nervous system disorders. The main sources and symptoms related to exposure to methanol were identified by means of a qualitative research conducted with a population of 42 workers from a biodiesel processing plant in the region of Quixadá, Brazil.Eight possible emission sources were identified among workers who were “potentially exposed” to methanol. These workers held jobs as operators, operations support, maintenancetechnicians, lab assistants and loading dock workers. A health examination analyses revealed that the majority of the “potentially exposed” workers already show pre-existing symptoms such as headaches, paraesthesia, heartburn and acid reflux. Irritability (38.1%), anxiety (35.7%), insomnia (64.3%) and predominantly, headaches(64.35%) are the recent most important complaints associated with neurotoxic symptoms. Other recent symptoms that could be associated with exposure to methanol are eye irritation (38.1%) shortness of breath (23.8%) and cramps (19%).


Asunto(s)
Humanos , Diagnóstico de la Situación de Salud , Exposición Profesional/efectos adversos , Metanol/efectos adversos , Metanol/toxicidad , Aceites Combustibles/efectos adversos , Aceites Combustibles/toxicidad , Brasil , Exposición a Compuestos Químicos , Salud Laboral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA